What Is Uric Acid? Normal vs Optimal Range Explained

Uric acid crystallizes in joints and tissues when blood concentrations exceed the saturation point of approximately 6.8 mg/dL at body temperature, but inflammatory damage begins well before crystals form. The lab upper limit of 7.2 mg/dL sits dangerously close to the crystallization threshold, meaning patients at the high end of normal are one dehydration episode or purine-rich meal away from a gout attack. The CTD maps over 1,500 chemical interactions affecting uric acid metabolism genes, revealing that medications, dietary factors, and metabolic conditions all influence uric acid levels through production, reabsorption, and excretion pathways. The optimal range below 5.5 mg/dL provides a meaningful safety margin below the crystallization point while maintaining uric acid's beneficial antioxidant properties—at normal concentrations, uric acid accounts for roughly 50 percent of plasma antioxidant capacity.

The connection between elevated uric acid and metabolic disease extends far beyond gout. PubMed indexes over 42,000 publications on uric acid, with accumulating evidence that levels above 6.0 mg/dL independently predict hypertension, type 2 diabetes, chronic kidney disease progression, and cardiovascular events. Fructose metabolism is a major driver: the liver metabolizes fructose through a pathway that generates uric acid as a byproduct, while simultaneously depleting cellular ATP. This is why high-fructose corn syrup consumption correlates strongly with both elevated uric acid and metabolic syndrome—the two are biochemically linked through the same hepatic pathway. Reducing fructose intake is often the single most effective dietary intervention for lowering uric acid.

FAERS documents over 18,000 adverse event reports for allopurinol and febuxostat—the two primary uric acid-lowering medications—highlighting the clinical importance of managing hyperuricemia. Thiazide diuretics and loop diuretics raise uric acid by competing for renal excretion at the same tubular transport sites, making diuretic-induced hyperuricemia one of the most common medication-driven causes. Low-dose aspirin (81 mg daily) also raises uric acid through the same renal mechanism, though the cardiovascular benefit typically outweighs this effect. For patients with recurrent gout, the target is not just below the lab normal of 7.2 mg/dL—rheumatology guidelines recommend maintaining uric acid below 6.0 mg/dL (and below 5.0 mg/dL for tophaceous gout) to dissolve existing crystal deposits and prevent new attacks.